Machine learning in the pharmaceutical industry
What machine learning could do, and barriers to its use, with global pharmaceutical companies, sector associations, regulators, start-ups and SMEs.
What machine learning could do, and barriers to its use, with global pharmaceutical companies, sector associations, regulators, start-ups and SMEs.
PubPeer users went from discussing papers to hunting down fraud—and have embroiled the site in the most important internet privacy case you've never heard of.
Laureates developed basic building blocks for molecular machines
The Nobel Prize epitomizes the winner-takes-all economics of credit allocation and distorts the history of science by personalizing discoveries that are truly made by groups of individuals.
Nature Physics now requires its published papers to include information on whether and how their underlying data are accessible to others.
Last month the United Nations released a report with recommendations on how to improve innovation and access to health technologies.
Climate change, biodiversity loss, antibiotic resistance, and other global challenges pose major collective action problems: A group benefits from a certain action, but no individual has sufficient incentive to act alone.
Undergraduates from small, elite institutions have the best chance of winning a Nobel prize.
A new report sheds light on the varied funding schemes available for postdocs in Europe
Failing to record the version of any piece of software or hardware, overlooking a single parameter, or glossing over a restriction on how to use another researcher's code can lead you astray.
Science funders and researchers need to recognize the time, resources and effort required to curate open data.
Billy Bryan and Furaha Asani look at how to get the most out of your doctoral studies.
P hacking is manipulating data and research methods to achieve statistical signifiance. And it could be why so many research papers are false.
Research must be sent to DfE two days before publishing
You’ll find communities thirsty for your findings – and a space to demonstrate measurable ‘impact’ to your heart’s content.
Open Knowledge International is delighted to announce the launch of the public preview beta version of OpenTrials at a panel session on ‘Fostering Open Science in Global Health’.
On Ada Lovelace Day, Jenny Rohn reflects on her own experience of fixing gender inequalities in science.
Accessible data are not enough. We need to invest in systems that make the information useful, say Elizabeth Pisani and colleagues.
Women in tech and science professions reflect on how things would be different if there were more women in the sectors.
Coca-Cola and PepsiCo have given millions of dollars to nearly 100 prominent health groups in recent years, while simultaneously spending millions to defeat public health legislation.